Literature DB >> 21308497

Drug-resistant tuberculosis in sub-saharan Africa.

Jeffrey Hafkin1, Victoria M Gammino, Joseph J Amon.   

Abstract

Drug-resistant tuberculosis (DRTB) is an emerging infectious disease threat to sub-Saharan Africa (SSA), particularly in the regions hit hardest by the HIV epidemic. Numerous challenges face clinicians and public health officials tasked with combating DRTB in SSA. These include difficulties providing effective diagnosis, treatment, and prevention of this illness. Furthermore, combating DRTB requires addressing various legal and ethical complexities. A sustained commitment to investigating as well as implementing new diagnostic, therapeutic, and preventative interventions is essential to defeating this threat.

Entities:  

Year:  2010        PMID: 21308497     DOI: 10.1007/s11908-009-0074-7

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  32 in total

1.  Increasing transparency in partnerships for health--introducing the Green Light Committee.

Authors:  Rajesh Gupta; J Peter Cegielski; Marcos A Espinal; Myriam Henkens; Jim Y Kim; Catherina S B Lambregts-Van Weezenbeek; Jong-Wook Lee; Mario C Raviglione; Pedro G Suarez; Francis Varaine
Journal:  Trop Med Int Health       Date:  2002-11       Impact factor: 2.622

Review 2.  Laboratory medicine in Africa: a barrier to effective health care.

Authors:  Cathy A Petti; Christopher R Polage; Thomas C Quinn; Allan R Ronald; Merle A Sande
Journal:  Clin Infect Dis       Date:  2005-12-20       Impact factor: 9.079

3.  Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa.

Authors:  Stephen D Lawn; Landon Myer; Linda-Gail Bekker; Robin Wood
Journal:  AIDS       Date:  2007-01-30       Impact factor: 4.177

4.  Ethical challenges in TB control in the era of XDR-TB.

Authors:  M J Selgelid; P M Kelly; A Sleigh
Journal:  Int J Tuberc Lung Dis       Date:  2008-03       Impact factor: 2.373

Review 5.  The mycobacteriology laboratory and new diagnostic techniques.

Authors:  Gail L Woods
Journal:  Infect Dis Clin North Am       Date:  2002-03       Impact factor: 5.982

Review 6.  Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes.

Authors:  Haileyesus Getahun; Mark Harrington; Rick O'Brien; Paul Nunn
Journal:  Lancet       Date:  2007-06-16       Impact factor: 79.321

7.  Management of HIV-infected patients with MDR- and XDR-TB in resource-limited settings.

Authors:  F Scano; M Vitoria; W Burman; A D Harries; C F Gilks; D Havlir
Journal:  Int J Tuberc Lung Dis       Date:  2008-12       Impact factor: 2.373

Review 8.  Facing the crisis: improving the diagnosis of tuberculosis in the HIV era.

Authors:  Mark D Perkins; Jane Cunningham
Journal:  J Infect Dis       Date:  2007-08-15       Impact factor: 5.226

9.  Natural ventilation for the prevention of airborne contagion.

Authors:  A Roderick Escombe; Clarissa C Oeser; Robert H Gilman; Marcos Navincopa; Eduardo Ticona; William Pan; Carlos Martínez; Jesus Chacaltana; Richard Rodríguez; David A J Moore; Jon S Friedland; Carlton A Evans
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

10.  Building clinical trials capacity for tuberculosis drugs in high-burden countries.

Authors:  Neil Schluger; Unni Karunakara; Christian Lienhardt; Thomas Nyirenda; Richard Chaisson
Journal:  PLoS Med       Date:  2007-11-06       Impact factor: 11.069

View more
  3 in total

1.  Tuberculosis incidence and treatment completion among Ugandan prison inmates.

Authors:  A Schwitters; M Kaggwa; P Omiel; G Nagadya; N Kisa; S Dalal
Journal:  Int J Tuberc Lung Dis       Date:  2014-07       Impact factor: 2.373

2.  Emerging threat of drug-resistant tuberculosis and trends in the era of COVID-19: A descriptive study from northwestern Nigeria.

Authors:  Farouq Muhammad Dayyab; Garba Iliyasu; Bashir Garba Ahmad; Ibrahim Aliyu Umar; Nura Musa Shuaib; Mamman Bajehson; Ibrahim Muhammad Daiyab; Oji Akpala; Olaoye Remilekun; Abdulrazaq Garba Habib
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2022-05-17

3.  Dipterinyl calcium pentahydrate inhibits intracellular mycobacterial growth in human monocytes via the C-C chemokine MIP-1β and nitric oxide.

Authors:  Isaac G Sakala; Christopher S Eickhoff; Azra Blazevic; Phillip Moheno; Richard F Silver; Daniel F Hoft
Journal:  Infect Immun       Date:  2013-03-18       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.